Letters

Sen. Proxmire gave more than "Golden Fleece Awards" (The Scientist, December 12, 1988, page 17), he also gave Americans a "Golden Fleece Law." In 1976, Proxmire's vitamin bill greatly restricting FDA's regulation of the safety and effectiveness of nutritional supplements slipped through Congress despite opposition from public health and consumer groups. The bill was backed primarily by manufacturers of these dubious products and by the health foods industry. To my knowledge, this was the only b

Written byWilliam Jarvis
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Sen. Proxmire gave more than "Golden Fleece Awards" (The Scientist, December 12, 1988, page 17), he also gave Americans a "Golden Fleece Law." In 1976, Proxmire's vitamin bill greatly restricting FDA's regulation of the safety and effectiveness of nutritional supplements slipped through Congress despite opposition from public health and consumer groups. The bill was backed primarily by manufacturers of these dubious products and by the health foods industry. To my knowledge, this was the only bill in this century to go against the principle of caveat vendor (let the seller beware) which applies when buyers and sellers are on unequal terms regarding the value and quality of what is being sold. Then FDA commissioner Alexander Schmidt called the Proxmire bill "a charlatan's dream." It has proved to be just exactly that as Americans are annually fleeced of hundreds of millions of dollars spent on completely worthless supplements allowed by his ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies